Stephanie Andrews Rita Holden
10.2147/CMAR.S31873
Cancer Manag Res
2012;4:299-307.
case studies immunotherapy ipilimumab melanoma
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/23049279/
PMC3459593
23049279
Characteristics and management of immunerelated adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma
2012